Cusack Thomas bought HRTX
November 8, 2025 · Form 4 insider transaction
Cusack Thomas bought 227,272 shares of Heron Therapeutics, Inc. at $1.10 per share, a transaction worth $250.0K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
227,272
Price
$1.10
Total value
$250.0K
InsiderCusack Thomas
RoleDirector
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateNovember 8, 2025
Filing dateNovember 12, 2025
Shares owned after227,272
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The stock options vest and become exercisable in 48 equal monthly installments beginning one month after the date of grant.